Health care company Dexcom sees shares slip amid potential competition from Apple
Shares of Dexcom briefly dipped on Thursday, after news that Apple may be developing technology to monitor blood sugar levels. Shares fell as low as $72.62 a share, but last traded around $76 a share, down less than 1 percent. Dexcom makes glucose monitoring products, including mobile apps, to help patients with diabetes. IPhone-maker Apple has been...